Dr. Roger Li, M.D
NPI: 1841515525
Total Payments
$32,913
2024 Payments
$13,414
Companies
12
Transactions
49
Medicare Patients
1,021
Medicare Billing
$111,226
Payment Breakdown by Category
Consulting$26,802 (81.4%)
Travel$3,549 (10.8%)
Other$1,500 (4.6%)
Food & Beverage$1,055 (3.2%)
Education$7.73 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $26,802 | 14 | 81.4% |
| Travel and Lodging | $3,549 | 13 | 10.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,500 | 1 | 4.6% |
| Food and Beverage | $1,055 | 20 | 3.2% |
| Education | $7.73 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $8,488 | 9 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $6,937 | 4 | $0 (2019) |
| UROGEN PHARMA, INC. | $4,800 | 1 | $0 (2021) |
| Merck Sharp & Dohme LLC | $4,426 | 13 | $0 (2024) |
| Janssen Global Services, LLC | $4,188 | 7 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $2,154 | 6 | $0 (2024) |
| PFIZER INC. | $1,695 | 4 | $0 (2024) |
| Astellas Pharma US Inc | $93.51 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $57.29 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $39.41 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,414 | 26 | Janssen Global Services, LLC ($4,188) |
| 2023 | $867.60 | 7 | Merck Sharp & Dohme LLC ($696.26) |
| 2022 | $2,730 | 1 | E.R. Squibb & Sons, L.L.C. ($2,730) |
| 2021 | $4,800 | 1 | UROGEN PHARMA, INC. ($4,800) |
| 2020 | $7.73 | 1 | Merck Sharp & Dohme Corporation ($7.73) |
| 2019 | $11,079 | 12 | Ferring Pharmaceuticals Inc. ($6,937) |
| 2017 | $15.80 | 1 | Dentsply Sirona Inc ($15.80) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $2,115.00 | General |
| 12/05/2024 | Janssen Global Services, LLC | — | Food and Beverage | In-kind items and services | $140.20 | General |
| 12/05/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $39.41 | General |
| Category: Oncology | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $57.29 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $545.00 | General |
| Category: VACCINE | ||||||
| 10/15/2024 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $1,350.00 | General |
| 09/25/2024 | Janssen Global Services, LLC | — | Travel and Lodging | In-kind items and services | $163.91 | General |
| 09/24/2024 | Janssen Global Services, LLC | — | Travel and Lodging | In-kind items and services | $145.86 | General |
| 09/24/2024 | Janssen Global Services, LLC | — | Travel and Lodging | In-kind items and services | $141.59 | General |
| 09/24/2024 | Janssen Global Services, LLC | — | Travel and Lodging | In-kind items and services | $131.30 | General |
| 09/05/2024 | Janssen Scientific Affairs, LLC | — | Travel and Lodging | In-kind items and services | $627.45 | General |
| 09/05/2024 | Janssen Scientific Affairs, LLC | — | Travel and Lodging | Cash or cash equivalent | $569.85 | General |
| 09/05/2024 | Janssen Scientific Affairs, LLC | — | Travel and Lodging | Cash or cash equivalent | $469.76 | General |
| 09/05/2024 | Janssen Scientific Affairs, LLC | — | Travel and Lodging | Cash or cash equivalent | $425.00 | General |
| 09/04/2024 | Janssen Scientific Affairs, LLC | — | Food and Beverage | Cash or cash equivalent | $39.49 | General |
| 09/04/2024 | Janssen Scientific Affairs, LLC | — | Travel and Lodging | Cash or cash equivalent | $22.12 | General |
| 08/13/2024 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| 07/29/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $272.50 | General |
| Category: VACCINE | ||||||
| 06/12/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $545.00 | General |
| 06/05/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $545.00 | General |
| 05/22/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $588.60 | General |
| 05/20/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,710.00 | General |
| 05/03/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Oncology | ||||||
| 03/20/2024 | Becton, Dickinson and Company | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Urology | ||||||
| 03/04/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $545.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 253 | 344 | $148,451 | $28,375 |
| 2022 | 6 | 229 | 306 | $118,056 | $24,543 |
| 2021 | 8 | 275 | 363 | $141,290 | $31,073 |
| 2020 | 5 | 264 | 326 | $108,460 | $27,235 |
Total Patients
1,021
Total Services
1,339
Medicare Billing
$111,226
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 95 | 172 | $78,466 | $9,850 | 12.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 53 | 65 | $11,520 | $4,957 | 43.0% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2023 | 16 | 18 | $18,378 | $3,860 | 21.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 38 | 38 | $10,274 | $3,664 | 35.7% |
| 52234 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | Facility | 2023 | 11 | 11 | $9,626 | $2,186 | 22.7% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 17 | 17 | $8,448 | $1,665 | 19.7% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 12 | 12 | $6,672 | $1,472 | 22.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 11 | 11 | $5,067 | $719.95 | 14.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 82 | 145 | $65,250 | $8,406 | 12.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 58 | 58 | $14,825 | $6,099 | 41.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 46 | 56 | $9,485 | $4,245 | 44.8% |
| 52234 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | Office | 2022 | 11 | 12 | $10,392 | $1,952 | 18.8% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2022 | 14 | 17 | $9,248 | $1,936 | 20.9% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 18 | 18 | $8,856 | $1,905 | 21.5% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 84 | 155 | $69,750 | $9,369 | 13.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 65 | 65 | $16,280 | $6,882 | 42.3% |
| 52234 | Destruction and/or removal of (0.5 to 2.0 centimeters) small growths of the bladder using an endoscope | Facility | 2021 | 18 | 20 | $17,320 | $4,046 | 23.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 40 | 50 | $7,710 | $3,887 | 50.4% |
| 52234 | Destruction and/or removal of (0.5 to 2.0 centimeters) small growths of the bladder using an endoscope | Office | 2021 | 13 | 14 | $12,124 | $2,731 | 22.5% |
| 55700 | Biopsy of prostate gland | Facility | 2021 | 18 | 18 | $8,856 | $1,883 | 21.3% |
| 52332 | Insertion of stent in urinary duct (ureter) using an endoscope | Facility | 2021 | 11 | 12 | $6,744 | $1,243 | 18.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 15 | 18 | $1,824 | $811.56 | 44.5% |
| 74420 | Imaging of urinary tract | Facility | 2021 | 11 | 11 | $682.00 | $221.10 | 32.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 96 | 96 | $24,000 | $9,633 | 40.1% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2020 | 65 | 107 | $48,150 | $6,811 | 14.1% |
About Dr. Roger Li, M.D
Dr. Roger Li, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Loma Linda, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2010. The National Provider Identifier (NPI) number assigned to this provider is 1841515525.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roger Li, M.D has received a total of $32,913 in payments from pharmaceutical and medical device companies, with $13,414 received in 2024. These payments were reported across 49 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($26,802).
As a Medicare-enrolled provider, Li has provided services to 1,021 Medicare beneficiaries, totaling 1,339 services with total Medicare billing of $111,226. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Urology
- Location Loma Linda, CA
- Active Since 04/06/2010
- Last Updated 02/17/2017
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1841515525
Products in Payments
- JELMYTO (Drug) $4,800
- KEYTRUDA (Biological) $703.99
- XTANDI (Drug) $93.51
- IMFINZI (Biological) $57.29
- ERLEADA (Drug) $39.41
- PADCEV (Biological) $23.30
- Bard Urinary Drainage Bag (Device) $20.09
- Aquasil (Device) $15.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Loma Linda
Bingbing Song, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $555,354
Student in an Organized Health Care Education/Training Program $555,354
Dr. Vaneet Sandhu, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $48,061
Student in an Organized Health Care Education/Training Program $48,061
Sarah Yoon, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $16,034
Student in an Organized Health Care Education/Training Program $16,034
Kristyn Mannoia, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $11,874
Student in an Organized Health Care Education/Training Program $11,874
Dr. Michael Krainock, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $10,673
Student in an Organized Health Care Education/Training Program $10,673
Nicole Yim, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $10,212
Student in an Organized Health Care Education/Training Program $10,212